FDA hands Cassiopea its first approval, for acne drug Winlevi
pharmaphorum
AUGUST 28, 2020
Shares in dermatology specialist Cassiopea, which is listed on the SWX exchange in Switzerland, rose almost 17% after news of the FDA approval emerged. By locally blocking androgens, Winlevi prevents the production of excess oil (sebum) and dampens down inflammation, according to the company.
Let's personalize your content